Flagship Harbor Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-136
Closed -$3K 2021
2020
Q2
$3K Buy
+136
New +$3.76K ﹤0.01% 1714

Other funds holding HCAT

Flagship Harbor Advisors's HCAT Position: Q3 2020 in Review

Flagship Harbor Advisors sold out of Health Catalyst (HCAT) in Q3 2020, closing a stake of 136 shares — an estimated $3K sold.

Flagship Harbor Advisors first reported a position in HCAT in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 138 funds tracked by Wall St. Rank hold HCAT as of Q3 2020.

  • Flagship Harbor Advisors reported no remaining Health Catalyst position as of Q3 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 136 Health Catalyst shares in Q3 2020, an estimated $3K.
  • Flagship Harbor Advisors first reported a position in Health Catalyst in Q2 2020 and held it in 1 quarter.
  • Flagship Harbor Advisors's Health Catalyst position peaked at $3K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2020.

Based on Flagship Harbor Advisors's 13F filing for Q3 2020, filed 13 Oct 2020.